Original Article
Molecular Therapy (2005) 11, 563–577; doi: 10.1016/j.ymthe.2004.10.021
Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses
Almudena Hurtado Picó1, Xiaomin Wang1, Isaac Sipo1, Ulrike Siemetzki*,1, Jürgen Eberle2, Wolfgang Poller1,† and Henry Fechner1,†
- 1Department of Cardiology & Pneumonology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
- 2Department of Dermatology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
Correspondence: Henry Fechner, Fax: +49 (30) 8445 4582. E-mail: Henry.Fechner@medizin.fu-berlin.de
*These authors have equally contributed to this work.
†Current address: Center for Immunopathogenesis and Infectious Diseases, Mailman School of Public Health, Columbia University, New York, NY 10027, USA.
Received 14 June 2004; Accepted 26 October 2004.
Abstract
Restricted replication-competent adenoviruses (RRCAs) using tumor- and tissue-specific promoters (ttsP's) are new tools for cancer gene therapy. In this study we investigated viral and nonviral factors affecting "leakiness" of several ttsP's and their relevance for nonspecific ttsP-dependent RRCA (ttsP-RRCA) replication. The leakiness of the ttsP's in nontarget cells was per se highly variable and correlated with levels of nonspecific ttsP-RRCA replication. Transcriptional regulator elements fused to ttsP's showed variable effects: a hypoxic response element reduced leakiness of an
-fetoprotein promoter. In contrast, a mouse tyrosinase enhancer increased leakiness of a tyrosinase promoter, although it was not affected by a human tyrosinase enhancer. Furthermore, leakiness of ttsP's was enhanced by 5'-terminal adenoviral E1A enhancers, and adenoviral E1A-13S was found to be a strong transactivator of ttsP's, leading to "autoactivation" of leaky ttsP-RRCAs. In a proof-of-principle study, ttsP-RRCA replication was shown to be inhibited by a tetracycline-controlled transcriptional silencer via direct ttsP silencing. This opens up the prospect of pharmacological regulation of ttsP-RRCAs. Together, these data indicate that leakiness of ttsP's induced by several factors is a major cause of nonspecific ttsP-RRCA replication. Consideration of these factors may help optimize ttsP-dependent RRCA vectors and may thereby improve their safety.
Keywords:
cancer gene therapy, oncolytic adenovirus, tumor- and tissue-specific promoter, tetracycline-controlled transcriptional silencer
Abbreviations:
ttsP, tumor- and tissue-specific promoter; RRCA, restricted replication-competent adenovirus; rdAdV, replication-deficient adenovector; tTS, tetracycline-controlled transcriptional silencer
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Bactericidal antisense effects of peptide?PNA conjugatesNature Biotechnology Research (01 Apr 2001)
Protein solubility and folding monitored in vivo by structural complementation of a genetic marker proteinNature Biotechnology Research (01 Feb 2001)
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacyNature Biotechnology Research (01 Nov 2001)
A novel tetracycline-controlled transactivator?transrepressor system enables external control of oncolytic adenovirus replicationGene Therapy Research Article
Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivoGene Therapy Original Article

